You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

Caffeine; ergotamine tartrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for caffeine; ergotamine tartrate and what is the scope of freedom to operate?

Caffeine; ergotamine tartrate is the generic ingredient in four branded drugs marketed by Novartis, Cosette, Sandoz, Hikma Intl Pharms, Mikart, and Organon Usa Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for caffeine; ergotamine tartrate. Four suppliers are listed for this compound.

Summary for caffeine; ergotamine tartrate
Pharmacology for caffeine; ergotamine tartrate

US Patents and Regulatory Information for caffeine; ergotamine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart ERGOTAMINE TARTRATE AND CAFFEINE caffeine; ergotamine tartrate TABLET;ORAL 040590-001 Sep 16, 2005 AA RX No No   Start Trial   Start Trial   Start Trial
Cosette MIGERGOT caffeine; ergotamine tartrate SUPPOSITORY;RECTAL 086557-001 Oct 4, 1983 RX No Yes   Start Trial   Start Trial   Start Trial
Novartis CAFERGOT caffeine; ergotamine tartrate TABLET;ORAL 006620-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Novartis CAFERGOT caffeine; ergotamine tartrate SUPPOSITORY;RECTAL 009000-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.